Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]

"Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]." ClinicoEconomics and Outcomes Research, , p. 567

This article refers to:

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting

Disclosure

The author reports no conflicts of interest in this work.

Following a review of the funding statement in the “Acknowledgments” section post-publication, “unrestricted educational grant” was mistakenly used. The author apologies for this oversight.